As of 2026-03-13, the Relative Valuation of IGEA Pharma NV (IGPH.SW) is 0.05 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 CHF, the upside of IGEA Pharma NV based on Relative Valuation is 3362.9%.
The range of the Relative Valuation is 0.03 - 0.06 CHF.
| Range | Selected | |
| Trailing P/E multiples | 26.3x - 26.6x | 26.4x |
| Forward P/E multiples | 14.3x - 24.0x | 19.2x |
| Fair Price | 0.03 - 0.06 | 0.05 |
| Upside | 2071.9% - 3940.1% | 3362.9% |
| Date | P/E |